# Smartvalve

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/smartvalve

- Industry: Consumer Services
- Headquarters: Savyon, Israel
- Website: www.smartvalves.com
- Total disclosed funding: $0.1M
- Latest round: Seed (Feb 1, 2026)
- Investors on record: 1

## About

Smartvalve is an Israel-based company specializing in advanced healthcare solutions, focusing on enhancing patient care through innovative fluid management technologies.Smartvalve is dedicated to providing innovative healthcare solutions through its flagship product, the SmartValves™. The company is headquartered in Savyon, Israel. In February 2026, Smartvalve raised USD 100,000 in Seed funding from Peregrine Ventures, marking its first deal and total amount raised. There are no available details regarding the founder's history or any potential changes in business strategy or operations.Smartvalve offers innovative healthcare solutions aimed at enhancing patient care, primarily through its flagship product, the SmartValves™. These advanced devices facilitate the precise management of fluid delivery in clinical environments by integrating with existing medical equipment, thereby improving medication flow and reducing errors. The primary users of SmartValves™ include hospitals and outpatient clinics focused on safety and efficiency. Smartvalve has a presence in key markets such as North America and Europe, which are experiencing increasing demand for advanced healthcare technologies.Smartvalve's revenue model is centered around direct sales to healthcare institutions and partnerships with medical supply distributors. Sales typically occur through bulk purchasing agreements with hospitals and clinics, enhancing procurement efficiency. Clients may also engage in subscription arrangements for maintenance services and software updates related to SmartValves™, ensuring continuous support. The sales strategy emphasizes the distinct capabilities and value of the SmartValves™, with pricing structures designed to cater to various customer segments, reflecting enhanced patient safety and operational efficiency.Smartvalve plans to leverage its recent funding to expand its product line and enter new markets. The company is currently designing additional healthcare solutions and aims to launch these products by the end of 2026. Furthermore, Smartvalve is targeting expansion into untapped markets in Asia and Latin America by 2027, capitalizing on the growing demand for healthcare innovations in these regions. The recent Seed funding of USD 100,000 will support these initiatives, enabling the company to enhance its product offerings and market presence.

## Funding rounds

- Seed, Feb 1, 2026, $0.1M — Peregrine Ventures

## Investors

- Peregrine Ventures (https://capitalatlas.ai/funds/peregrine-ventures) — Seed